Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EXICURE, INC.XCUR · Entity 8068 | Chief Financial Officer | May 16, 2022 | May 18, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EXICURE, INC.
Report date May 16, 2022 · Filed May 18, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.12 · Expires 2032-05-15 | Direct | 424,000 |
Reported balance
After 2022-05-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-05-16 · Grant · Acquired 424,000 · Balance 424,000 F1: One-fourth (1/4th) of the shares will vest on May 16, 2023 and the remainder of the shares will vest in a series of thirty-six (36) successive equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting dates. |
Filing footnotes · ownership attribution and instrument terms
F1: One-fourth (1/4th) of the shares will vest on May 16, 2023 and the remainder of the shares will vest in a series of thirty-six (36) successive equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting dates.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 16, 2022 Filed May 18, 2022 16:34 UTC | EXICURE, INC. XCUR · Entity 8068 | GrantEmployee Stock Option (right to buy) · Derivative | 424,000 | $0.00 Strike: $0.12 | $0.00 |
DisclosureSEC source: 0001209191-22-030053 · doc4.xml · derivative · entry 1 Papadimas Elias D. · CIK 0001865732 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 424,000 Underlying: Common Stock · 424,000 shares Expires 2032-05-15 F1 · derivative.exercise_date: One-fourth (1/4th) of the shares will vest on May 16, 2023 and the remainder of the shares will vest in a series of thirty-six (36) successive equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting dates. Read SEC document |
| August 27, 2021 Filed Sep 8, 2021 07:00 UTC | EXICURE, INC. XCUR · Entity 8068 | PurchaseCommon Stock | 10,000 | $1.38 | $13,800.00 |
DisclosureSEC source: 0001209191-21-055098 · doc4.xml · nonDerivative · entry 1 Papadimas Elias D. · CIK 0001865732 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse's IRA Disclosed balance after: 10,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.375 to $1.38 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.